All the Active Ingredient Drugs
Selective α1 Blocker. Terazosin (as monohydrochloride dihydrate) 2 mg. TABS: Starter Pack: 7 x 1 mg, 2 mg. 28 x 5 mg, 10 mg. Initial: 1 x 1 mg tab 1 x
dly at bedt. Incr. step-wise to 2 mg, 5 mg
or 10 mg 1 x dly to achieve desired
effect.
Sympt. tmt. urinary obstruct. caused by
BPH, mild to mod. hypertens.
Selective α1 Blocker. Terazosin HCl dihydrate 5 mg. TABS: 30 x 5 mg. If discont. for
several days, tmt. should be reinstitut.
start. initial dos. regimen. BPH: Initial:
1 mg at bedt., not to be exceed.
Monitor during initial admin., risk of
severe hypotens. Incr. stepwise to 2
mg, 5 mg or 10 mg 1 x dly. 10 mg 1 x
dly gen. req. for clin. response. Cont.
for min. 4-6 wks. to assess benefic.
response. Caution dur. concom. admin.
other antihypertens., espec. verapamil,
to avoid hypotens. Dose reduct./
retitrat. may be necess. Hypertens:
Adjust dose (12/24 hrs) acc. pts. BP
response. Initial: 1 mg at bedt., not to
be exceed. Monitor during initial
admin., risk of severe hypotens. May
be slowly incr., 1 mg-5 mg 1 x dly,
some pts. 20 mg/day. Monitor BP at
end of dos. interval; also 2-3 hrs. after
dosing for excessive hypotens.
response. If response is diminished at
24 hrs, consider incr. dose or 2 x dly
reg. Except initial dose, admin. in
morning.
Symptomat. tmt. urinary obstruct.,
caused by BPH. Mild-mod. hypertens.
C/I: Known hypersens.
